Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its Persona Revision SoluTion Femur.

Zimmer Biomet Holdings, Inc. , a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTiontm Femur, a revision knee ...

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will participate in the ...

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce that the latest annual report ...

NHS Trust records four new incidents post-surgeon dismissal for prosthesis errors, bringing total to nine in five years.